You're here:   Home News In the News Perrigo Co.’s latest acquisition is designed to boost its product line for diabetes care


Perrigo Co.’s latest acquisition is designed to boost its product line for diabetes care

Tuesday, January 24, 2012
Print
     Order Reprints

Perrigo Co.’s latest acquisition is designed to boost its product line for diabetes care. The Allegan-based company signed a definite agreement to acquire the assets of Alpharetta, Georgia-based CanAm Care for $36 million.

CanAm distributes products for diabetes patients, including syringes, pen needles, lances, compression stockings and hypoglycemia tabs, liquids and gels. Perrigo makes the acquisition amid a growing rate in the U.S. for diabetes care, a market estimated at $1.5 billion annually. “Perrigo will be the only full-line store brand supplier to our retail customers in the over-the-counter diabetes care market with this combined portfolio,” Chairman and CEO Joe Papa said.

Add comment

You must login or register to post a comment.